Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients. Jun 2013 Am J Hematol aplastic anemia
Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes Jan 2014 Am J Hematol myelodysplastic syndromes (MDS)
Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management Jul 2012 Am J Hematol myelodysplastic syndromes (MDS)
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R Sep 2017 Am J Hematol myelodysplastic syndromes (MDS)
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry Jan 2019 Am J Hematol aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria Jan 2018 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes Aug 2012 Am J Hematol myelodysplastic syndromes (MDS)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)